We are excited to present the latest data from our RGLS4326 program for the treatment of ADPKD," co | RGLS Message Board Posts


Regulus Therapeutics Inc.

  RGLS website

RGLS   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  716 of 746  at  6/21/2021 3:16:15 PM  by

Steve_382


 In response to msg 715 by  arthurs1
view thread

Re: We are excited to present the latest data from our RGLS4326 program for the treatment of ADPKD," commented Jay Hagan, President and Chief Executive Officer of Regulus. "This year's conference is an opportune occasion to share with the PKD community ou

 Let's hope the excitement is justified. ;<)


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 2  
   Views: 0 []
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
717 Re: We are excited to present the latest data from our RGLS4326 program for the treatment of ADPKD," commented Jay Hagan, President and Chief Executive Officer of Regulus. "This year's conference is an opportune occasion to share with the PKD community ou Southerncross1 0 6/21/2021 7:10:22 PM


Financial Market Data provided by
.
Loading...